Verdict87/ 100
Ranked #7 · Grade B+Editorial review
Ro review
A heavyweight telehealth brand with brand-name access and a polished experience — but opaque compounded pricing.
Visit Ro Editorial review — no commercial relationship.
- Semaglutide
- Not disclosed
- Tirzepatide
- Not disclosed
- Coverage
- Multi-state
- Brand-name
- Yes
The scorecard
Ro scored on our six published factors. See the methodology.
Real-world results89/100
Price honesty80/100
Prescriber access90/100
Formulary choice92/100
Cancellation fairness86/100
Member support88/100
What we like
- Brand-name (Wegovy/Zepbound) access and insurance support
- Oral options
- Polished, well-funded platform
The caveats
- Does not publicly disclose compounded pricing up front
- Premium positioning
The verdict
Best for: Patients who want a big, brand-name-capable platform and insurance navigation. A heavyweight telehealth brand with brand-name access and a polished experience — but opaque compounded pricing.
Pricing, states and verification reflect Ro's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Ro's site. Not medical advice; see our disclosure.